Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Hardcover, 1st ed. 2017)

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities. The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Milestones in Drug Therapy
Release date:	April 2017
First published:	2017
Editors:	Ulf Grawunder • Stefan Barth
Dimensions:	235 x 155 x 13mm (L x W x T)
Format:	Hardcover
Pages:	181
Edition:	1st ed. 2017
ISBN-13:	978-3-319-46875-4
Categories:	Books > Medicine > Other branches of medicine > Pharmacology > General Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General Promotions
LSN:	3-319-46875-8
Barcode:	9783319468754

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!